BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17605023)

  • 21. Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women.
    Reginster JY; Agnusdei D; Gennari C; Kicovic PM
    Gynecol Endocrinol; 1999 Oct; 13(5):361-8. PubMed ID: 10599554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.
    McClung MR; Siris E; Cummings S; Bolognese M; Ettinger M; Moffett A; Emkey R; Day W; Somayaji V; Lee A
    Menopause; 2006; 13(3):377-86. PubMed ID: 16735934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
    Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
    Tiitinen A; Nikander E; Hietanen P; Metsä-Heikkilä M; Ylikorkala O
    Maturitas; 2004 Jul; 48(3):321-7. PubMed ID: 15207898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M
    Hypertens Res; 2008 Jun; 31(6):1191-7. PubMed ID: 18716368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
    Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS).
    Eastell R; Nickelsen T; Marin F; Barker C; Hadji P; Farrerons J; Audran M; Boonen S; Brixen K; Gomes JM; Obermayer-Pietsch B; Avramidis A; Sigurdsson G; Glüer CC
    J Bone Miner Res; 2009 Apr; 24(4):726-36. PubMed ID: 19049337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS).
    Kemmler W; Lauber D; Weineck J; Hensen J; Kalender W; Engelke K
    Arch Intern Med; 2004 May; 164(10):1084-91. PubMed ID: 15159265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S; Karner I
    Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C; Dane B; Cetin A; Erginbas M
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.
    Ribom EL; Ljunggren O; Mallmin H
    J Clin Densitom; 2008; 11(3):404-11. PubMed ID: 18280191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intermittent compression therapy on bone mineral density in women with low bone mass.
    Albertazzi P; Steel SA; Bottazzi M
    Bone; 2005 Nov; 37(5):662-8. PubMed ID: 16099227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intramuscular clodronate on bone mass and metabolism in osteoporotic women.
    Gnudi S; Lisi L; Fini M; Malavolta N
    Int J Tissue React; 2001; 23(1):33-7. PubMed ID: 11392061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
    Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus.
    Al-Maatouq MA; El-Desouki MI; Othman SA; Mattar EH; Babay ZA; Addar M
    Saudi Med J; 2004 Oct; 25(10):1423-7. PubMed ID: 15494815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
    Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
    Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
    Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
    Gallagher JC; Baylink DJ; Freeman R; McClung M
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4717-26. PubMed ID: 11600531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study.
    Minne H; Audran M; Simões ME; Obermayer-Pietsch B; Sigurðsson G; Marín F; Dalsky GP; Nickelsen T;
    Curr Med Res Opin; 2008 Nov; 24(11):3117-28. PubMed ID: 18838053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.